Literature DB >> 7504085

Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.

P Celada1, F Artigas.   

Abstract

We have examined the changes induced by the monoamine oxidase (MAO; EC 1.4.3.4) inhibitors tranylcypromine, clorgyline, and deprenyl on MAO activity and 5-hydroxytryptamine (serotonin, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) content in rat brain and blood (plasma and whole blood). The decreases of MAO-A activity observed in the liver and lungs after different doses of clorgyline or tranylcypromine correlated significantly (r > 0.80 in all cases) with the decline of plasma 5-HIAA. This was unaffected by 0.25 and 5 mg kg-1 of deprenyl, indicating that 5-HT was deaminated exclusively in the periphery by MAO-A. It is interesting that very potent and significant correlations (r > 0.75) were found between plasma 5-HIAA and MAO-A activity, 5-HIAA and 5-HT content in brain tissue. These results suggest that plasma 5-HIAA can be used confidently as a peripheral indicator of the inhibition of MAO-A in brain. This may represent a favorable alternative to the analysis of 5-HIAA in CSF in psychiatric patients undergoing antidepressant treatment with nonspecific MAO inhibitors or with the new selective MAO-A inhibitors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504085     DOI: 10.1111/j.1471-4159.1993.tb07459.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.

Authors:  A Moser; F Siebecker; P Vieregge; P Jaskowski; D Kömpf
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.

Authors:  N Bel; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

3.  20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition.

Authors:  Amélie Piton; Hélène Poquet; Claire Redin; Alice Masurel; Julia Lauer; Jean Muller; Julien Thevenon; Yvan Herenger; Sophie Chancenotte; Marlène Bonnet; Jean-Michel Pinoit; Frédéric Huet; Christel Thauvin-Robinet; Anne-Sophie Jaeger; Stéphanie Le Gras; Bernard Jost; Bénédicte Gérard; Katell Peoc'h; Jean-Marie Launay; Laurence Faivre; Jean-Louis Mandel
Journal:  Eur J Hum Genet       Date:  2013-10-30       Impact factor: 4.246

4.  Plasma 5-HIAA activity indicative of serotonergic disturbances in cognitively impaired, elderly patients experiencing postoperative delirium.

Authors:  Annelies Heylen; Yannick Vermeiren; Sophia E De Rooij; Rikie M Scholtens; Barbara C Van Munster; Debby Van Dam; Peter P De Deyn
Journal:  Int J Geriatr Psychiatry       Date:  2022-02       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.